People in Hezhou, China, who live longer have less Bifidobacterium in their gut than younger people, which contradicts the idea that Bifidobacterium is always beneficial during aging.
See the scientific wording
Long-lived individuals in Hezhou, China, exhibit a lower abundance of Bifidobacterium in their gut microbiota compared to younger adults, challenging the assumption that Bifidobacterium is universally beneficial in aging.
Correlational — new studies may shift this
ObservationalOne moderate-quality study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cohort StudyHuman2025
People who live to 90 or older in this study had less of a gut bacteria called Bifidobacterium than younger people, which is surprising because most people think this bacteria is always good for you. This suggests it might not be necessary for living a very long life.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
In long-lived people, gut bacteria that make butyrate and lactic acid become more common. These acids lower gut acidity, block harmful bacteria, and strengthen the gut lining. This reduces chronic inflammation and removes the need for Bifidobacterium to maintain gut health, so it becomes less common.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
People in Hezhou, China, who live longer have less Bifidobacterium in their gut than younger people, which contradicts the idea that Bifidobacterium is always beneficial during aging.
Mechanism
1 studyIn very old people, gut bacteria that make butyrate and lactic acid become dominant. These substances seal the gut lining and quiet inflammation, so the gut no longer needs Bifidobacterium to stay healthy. As a result, Bifidobacterium naturally decreases because it is no longer needed.
In long-lived people, gut bacteria that make butyrate and lactic acid become more common. These acids lower gut acidity, block harmful bacteria, and strengthen the gut lining. This reduces chronic inflammation and removes the need for Bifidobacterium to maintain gut health, so it becomes less common.
Firmicutes bacteria ferment dietary fiber to produce short-chain fatty acids, primarily butyrate
Butyrate enters colon cells and inhibits histone deacetylases, leading to reduced expression of pro-inflammatory cytokines and increased production of tight junction proteins
Lactobacillus bacteria ferment carbohydrates to produce lactic acid, lowering luminal pH and inhibiting growth of pathogenic bacteria
Lactic acid and butyrate together enhance mucosal immunity by increasing secretory IgA and reducing microbial translocation
Reduced systemic inflammation and a stable, pathogen-resistant gut environment eliminate the functional necessity for high Bifidobacterium abundance
Evidence from Studies
Supporting (1)
Community contributions welcome
Characteristics of gut microbiota in longevity populations in China and its relationship with healthy aging
People who live to 90 or older in this study had less of a gut bacteria called Bifidobacterium than younger people, which is surprising because most people think this bacteria is always good for you. This suggests it might not be necessary for living a very long life.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Gut Microbiota Composition in Long-Lived Human Populations Compared to Younger Controls
Population: Long-lived individuals (≥90 years) and younger adults (20–40 years) from diverse global populations; Intervention: None (observational); Comparator: Age-matched controls; Outcome: Relative abundance of Bifidobacterium in fecal microbiota; Duration: Single time point sampling across studies.
Prospective Cohort Study of Gut Microbiota Trajectories in Aging Populations in Hezhou, China
Population: Healthy adults aged 40–60 in Hezhou, China; Intervention: None (observational); Comparator: Individuals who later become long-lived vs. those who do not; Outcome: Change in Bifidobacterium abundance over 20+ years; Duration: 20+ years of follow-up.
Cross-Sectional Comparison of Gut Microbiota in Long-Lived and Younger Adults in Hezhou, China
Population: Long-lived individuals (≥90 years) and younger adults (20–40 years) in Hezhou, China; Intervention: None; Comparator: Age groups; Outcome: Fecal Bifidobacterium abundance measured by 16S rRNA sequencing; Duration: Single time point.
In Vitro Assessment of Bifidobacterium Strains from Long-Lived Individuals on Human Intestinal Epithelial Cell Viability and Inflammatory Markers
Population: Bifidobacterium strains isolated from fecal samples of long-lived and younger adults in Hezhou; Intervention: Co-culture with human intestinal epithelial cells; Comparator: Strains from long-lived vs. younger donors; Outcome: Cell viability, cytokine secretion, barrier integrity; Duration: 24–72 hours.
Gnotobiotic Mouse Study Transplanting Gut Microbiota from Long-Lived and Younger Humans to Assess Impact on Lifespan and Healthspan
Population: Germ-free mice; Intervention: Fecal microbiota transplantation from long-lived and younger human donors in Hezhou; Comparator: Two transplant groups; Outcome: Lifespan, inflammation, metabolic markers; Duration: Lifetime of mice (2–3 years).